Biomolecular science

Understanding the disease

Our biomolecular science researchers are working to improve understanding of the disease process at the molecular level and develop better diagnostics and therapeutics to combat disease.

We're using state-of-the-art technologies to investigate the molecular basis of disease by studying:

  • cell and tissue structure
  • cell interactions and signalling
  • DNA and protein sequences
  • systems biology integration.

Our researchers have strength and expertise in:

  • cancer biology
  • immunology
  • microbiology
  • infectious disease
  • vaccine development
  • stem cell and tissue regeneration research.

Genomics Research Centre

Located within the Institute of Health and Biomedical Innovation, the Genomics Research Centre (GRC) undertakes research on the genetic basis of disease.

We focus on common chronic human disorders - for example, migraine, high blood pressure and cancer - that have a significant genetic component. Our researchers are working to identify the genes involved in these disorders, leading to better forms of diagnosis and treatment.

Our scientists are experts in gene mapping and the characterisation of gene dysfunction. They translate this information to diagnostic and therapeutic outcomes through techniques like DNA mutation testing and vaccine development.

The centre is funded by national competitive grants and industry, and employs over thirty research staff, including a number of established and long-standing collaborating clinicians.

Media releases

Related research projects

Australian Translational Genomics Centre

The Australian Translational Genomics Centre (ATGC) is the first genomic diagnostic service in Queensland, and one of the largest programs of its kind in Australasia, providing whole-exome or whole-genome sequencing and microarray services.

Genomics Research Centre

The GRC undertakes research on the genetic basis of disease

Peptide Therapeutics & Membrane Biology Research Group

Design and function of anticancer and antimicrobial peptides.